Clinical trial Recruiting at 1 site Interventional Ages 10 and up

Probiotic treatment for orthodontic patients

Official title: Effect of the Probiotic Strain Streptococcus Salivarius M18 on de Novo Formation and Composition of Dental Biofilm in Orthodontic Patients: A Randomized Double-blind Placebo-controlled Clinical Trial.

Run by University of Aarhus · NCT06751979 · Data updated 2026-11-12

This study is testing if a probiotic lozenge can help reduce dental plaque and cavities in healthy orthodontic patients wearing braces.

Quick facts

Study typeInterventional
Ages10 Years and up
SexAll
Enrollment60 (estimated)
SponsorUniversity of Aarhus
Academic / other
Locations1 site (Aarhus)
StatusRecruiting
StartedOctober 2, 2024
Main results expectedMarch 2025
Study endsMarch 2025
Registry record updatedDecember 30, 2024
Trial IDNCT06751979 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are generally healthy individuals aged 10 and older who are currently undergoing orthodontic treatment and have a moderate level of dental plaque.

Probably not a fit

Patients with significant oral health issues, allergies to probiotics, or those on certain medications may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effects of a lozenge containing the probiotic strain S. salivarius M18 on dental plaque and caries in healthy orthodontic patients. Participants will receive either the probiotic treatment or a placebo while undergoing orthodontic treatment with fixed appliances. The study aims to assess changes in the formation, composition, and virulence of dental plaque over the treatment period. Eligible participants must have a certain level of plaque and be generally healthy with at least 20 natural teeth.

Why it matters

Potential benefit: If successful, this treatment could reduce dental plaque and caries in orthodontic patients, improving oral health outcomes.

How similar studies have gone: While the specific probiotic approach may be novel, other studies have shown promising results with probiotics in oral health.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Generally healthy males and females ≥ 10 years of age.
2. Able to read and receive a copy of the signed informed consent form.
3. Have at least 20 natural teeth.
4. Have been undergoing orthodontic treatment with fixed orthodontic appliances in the upper and/or lower jaw \> 6 months.
5. An average plaque score of \> 2 according to the Modified Orthodontic Plaque Index (MOPI) at the screening appointment.

Exclusion Criteria:

1. Significant oral soft tissue pathology based on a visual examination.
2. History of allergy or significant adverse events following use of oral hygiene products such as toothpastes, mouth rinses, breath mints, lozenges, or chewing gum or their ingredients.
3. History of allergies to milk proteins.
4. History of allergies towards probiotics.
5. Self-reported as pregnant or nursing.
6. Self-reported serious medical conditions.
7. Antibiotic or anti-inflammatory medication within 30 days of screening visit.
8. Acute sinusitis or severe oral-pharyngeal infections.
9. Smoker.

Where it's running

  • Aarhus University, Department of Dentistry and Oral Health
    Aarhus, Denmark
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.